Nexplanon saw its best annual performance ever, growing 17% ex-FX in 2024 and on track to achieve $1 billion in revenue for 2025. International growth was particularly strong in the LAMERA region ...

Nexplanon is expected to reach at least $1 billion in revenue for 2025. Q4 2024 revenue reached $1.6 billion, with a full-year total of $6.4 billion. Adjusted EBITDA for 2024 was $1.96 billion ...

In November 2011, Nexplanon® was released. Nexplanon has a redesigned inserter intended to minimize deep insertions. The active ingredients in the new device are unchanged; however, Nexplanon ...